The estimated Net Worth of James Edeerfield Capital Lp... is at least $41.6 Milión dollars as of 26 May 2011. James Lp owns over 650,000 units of Rigel Pharmaceuticals stock worth over $41,558,046 and over the last 13 years James sold RIGL stock worth over $0.
James has made over 1 trades of the Rigel Pharmaceuticals stock since 2011, according to the Form 4 filled with the SEC. Most recently James bought 650,000 units of RIGL stock worth $5,200,000 on 26 May 2011.
The largest trade James's ever made was buying 650,000 units of Rigel Pharmaceuticals stock on 26 May 2011 worth over $5,200,000. On average, James trades about 650,000 units every 0 days since 2011. As of 26 May 2011 James still owns at least 3,204,167 units of Rigel Pharmaceuticals stock.
You can see the complete history of James Lp stock trades at the bottom of the page.
Over the last 21 years, insiders at Rigel Pharmaceuticals have traded over $170,041,384 worth of Rigel Pharmaceuticals stock and bought 2,068,700 units worth $7,281,949 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Ansbert Gadicke a Partners L P/Ilbiotechnolog.... On average, Rigel Pharmaceuticals executives and independent directors trade stock every 46 days with the average trade being worth of $961,207. The most recent stock trade was executed by David A Santos on 2 February 2024, trading 14,519 units of RIGL stock currently worth $16,552.
rigel pharmaceuticals, inc., is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases.
Rigel Pharmaceuticals executives and other stock owners filed with the SEC include: